# MethylGene Inc.: Form D filings

MethylGene Inc., a biotechnology company in Montreal, Quebec, Canada, filed 4 Form D notices with the SEC between 2011 and 2012. The latest, on November 21, 2012, reports $26.1 million sold of a $35.5 million offering to 17 investors.

Find out what MethylGene Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20MethylGene%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=MethylGene%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmethylgene-inc-1516722)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20MethylGene%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=MethylGene%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmethylgene-inc-1516722)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 7150 FREDERICK BANTING STREET, SUITE 200, Montreal, Quebec, Canada, H4S 2
- Phone: (514) 337-3333
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Canada (Federal Level)
- Revenue range: $1,000,001 - $5,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1516722

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 21, 2012 | New notice | $35,530,414 | $26,125,730 | $9,404,684 | 17 | Nov 9, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1516722/000151672212000005/0001516722-12-000005-index.htm) |
| Nov 16, 2012 | Amendment | $48,270,612 | $35,556,560 | $12,714,052 | 20 | Mar 24, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1516722/000151672212000004/0001516722-12-000004-index.htm) |
| Sep 11, 2012 | Amendment | $48,270,612 | $35,556,560 | $12,714,052 | 20 | Mar 24, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1516722/000151672212000003/0001516722-12-000003-index.htm) |
| Apr 7, 2011 | New notice | $48,301,344 | $35,513,141 | $12,788,203 | 20 | Mar 24, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1516722/000151672211000001/0001516722-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| GREGORY B. REID | Executive Officer |  |
| HENRY J. FUCHS | Director |  |
| KLAUS B. KEPPER | Executive Officer |  |
| RACHEL B. HUMPHREY | Executive Officer |  |
| RODNEY W. LAPPE | Director |  |
| PETER W. THOMPSON | Director |  |
| JOSEPH B. WALEWICZ | Executive Officer |  |
| JEFFREY M. BESTERMAN | Executive Officer |  |
| PEGGY W. MULLIGAN | Director |  |
| MARTIN GODBOUT | Executive Officer, Director |  |
| CHARLES W. BAUM | Executive Officer, Director |  |
| ARKADII B. VAISBURG | Executive Officer |  |

[Every Form D from the week of Nov 19, 2012](https://specstream.ai/data/form-d/week/2012-11-19) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what MethylGene Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).